1. Home
  2. RCS vs EMBC Comparison

RCS vs EMBC Comparison

Compare RCS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Strategic Income Fund Inc.

RCS

PIMCO Strategic Income Fund Inc.

HOLD

Current Price

$4.93

Market Cap

246.0M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$5.93

Market Cap

279.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCS
EMBC
Founded
1994
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.0M
279.9M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
RCS
EMBC
Price
$4.93
$5.93
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $18.50
AVG Volume (30 Days)
160.6K
★ 1.1M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
★ 10.12%
6.88%
EPS Growth
N/A
★ 20.90
EPS
N/A
★ 1.03
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.46
Revenue Growth
N/A
N/A
52 Week Low
$4.84
$2.77
52 Week High
$8.00
$14.91

Technical Indicators

Market Signals
Indicator
RCS
EMBC
Relative Strength Index (RSI) 31.70 68.28
Support Level N/A $4.84
Resistance Level $5.67 $5.91
Average True Range (ATR) 0.08 0.24
MACD -0.01 0.02
Stochastic Oscillator 24.29 97.64

Price Performance

Historical Comparison
RCS
EMBC

About RCS PIMCO Strategic Income Fund Inc.

PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: